Royal Jelly — Research Profile

What the Research Says

The recent postmenopausal-symptom review included six studies with 471 participants overall; its pooled symptom effect was based on two studies with 312 participants [7]. The limited evidence should not be generalized to hormone balancing or fertility treatment. Morita’s trial studied healthy volunteers over six months, not IVF patients [13].

Guo’s small lipid study used 6 g/day for four weeks, not six weeks [2]. Park’s skin work involved cultured fibroblasts and did not demonstrate wrinkle reduction in people [14]. Reviews of glycemic outcomes are inconsistent and include null results [8,9]. Preclinical hormone or cancer findings cannot establish cancer prevention [10].

Case reports document anaphylaxis, asthma and a possible warfarin interaction. People with bee-product allergy or hormone-sensitive cancer should avoid royal jelly, and those with asthma should seek medical advice rather than attempting a home tolerance test [12].

Benefits of Royal Jelly

• Menopausal symptoms — a recent review included six studies; the pooled symptom estimate came from two studies with 312 participants. It does not validate every preparation or replace individualized menopause care [7].
• Fertility — Morita’s 2012 trial enrolled healthy adults, not women undergoing IVF. It does not support the earlier follicular-development claim [13].
• Lipids — a 15-person study used 6 g/day for four weeks and reported total and LDL-cholesterol changes. This is a small biomarker study, not proof of cardiovascular protection [2].
• Skin — Park’s 2011 research used cultured human skin cells, not an oral trial showing reduced wrinkles. Cell findings do not establish oral or topical clinical benefit [14].

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

• Allergic reactions — the most serious concern; ranges from contact dermatitis and GI upset to severe anaphylaxis, especially in individuals with bee product or pollen allergies
• GI discomfort — nausea, stomach cramps, and diarrhea reported at higher doses
• Asthma exacerbation — royal jelly has triggered bronchospasm and asthma attacks in sensitized individuals
• Contact dermatitis when applied topically in allergic individuals
• Hormonal effects — estrogenic activity may be undesirable for individuals with hormone-sensitive conditions

Drug & Supplement Interactions

• Anticoagulants (warfarin) — royal jelly may have mild anticoagulant effects; monitor for increased bleeding
• Hormone replacement therapy — additive estrogenic effects due to 10-HDA's estrogen receptor activity
• Antihypertensives — royal jelly peptides may lower blood pressure; additive hypotensive effect possible
• Immunosuppressants — royal jelly may modulate immune function; theoretical concern for transplant patients